Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mirmehdi Mehdiyev
Observed name:
M. Mehdiyev
Institution:
Ankara Bilkent City Hospital
Observed institution:
Ankara Bilkent City Hospital
ORCID:
0009-0007-1740-625X
Observed ORCID:
0009-0007-1740-625X
OpenAlex ID:
A5115723502
Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer
2024
·
Furkan Ceylan
, Mirmehdi Mehdiyev
, et al.
·
Journal of Clinical Medicine
·
3
PDF
Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis
2025
·
Furkan Ceylan
, Mirmehdi Mehdiyev
, et al.
·
Cancers
·
2
PDF
Prognostic Value of the Hemoglobin Albumin Lymphocyte Platelet Score in Extrapulmonary Neuroendocrine Carcinomas
2025
·
Perihan Perkin
, Serhat Sekmek
, et al.
·
Acta haematologica oncologica Turcica.
·
1
PDF
Survival Outcomes in ERBB2- Low vs ERBB2- Null Advanced Gastric Cancer
2026
·
Beliz Bahar Karaoğlan
, Eduardo Terán
, et al.
·
JAMA Network Open
429P Prognostic significance of HER2-low status in advanced gastric cancer
2025
·
B.B. Karaoglan
, M. Mehdiyev
, et al.
·
Annals of Oncology
PDF
From genotype to protein: how the 308 G/A polymorphism of the TNF-α gene is associated with TNF-α protein levels in patients with Hashimoto’s thyroiditis
2025
·
R. R. Rahimova
, G. Azizova
, et al.
·
Zaporozhye Medical Journal
Show more works
View as search
Works count:
6
Citation count:
6
H-index:
2
I10-index:
Year
Topic
Type